Diabetic Ketoacidosis Disease

BASICS

DESCRIPTION
A true medical emergency secondary to absolute or relative insulin deficiency characterized by hyperglycemia, ketonemia, metabolic acidosis, and electrolyte depletion
  • System(s) affected: Endocrine/Metabolic
  • Genetics: N/A
  • Incidence/Prevalence in USA: 46 episodes/10,000 diabetic patients; 2 per 100 patient years of type 1 DM
  • Predominant age: 0-19 years of age
  • Predominant sex: Male = Female
SIGNS AND SYMPTOMS
  • Polyuria
  • Polydipsia
  • Generalized weakness
  • Malaise/lethargy
  • Nocturia
  • Nausea/vomiting
  • Abdominal pain and tenderness
  • Decreased bowel sounds
  • Decreased perspiration
  • Hypotension
  • Hypothermia
  • Decreased reflexes
  • Coma
  • Confusion
  • Tachycardia
  • Tachypnea
  • Fever +/-
  • Breath fruity, with acetone smell
  • Dry mucous membranes
  • Anorexia or increased appetite
CAUSES
  • Insulin dependent diabetes mellitus (20-30% in newly diagnosed diabetics)
  • Infarction (myocardial) 5-7%
  • Infection (30-40%) usually respiratory or urinary
  • Idiopathic (20-30%)
  • Medication non-compliance
  • CVA
  • Trauma
  • Surgery
  • Emotional stress
RISK FACTORS
  • Any condition that leads to an absolute or relative insulin deficiency
  • History of corticosteroid therapy

DIAGNOSIS

LABORATORY
  • Blood sugar elevated (usually 250-800 mg/dL [13.88-44.4 mmol/L] range)
  • Serum ketosis
  • Urine ketosis
  • Glycosuria
  • Hyponatremia
  • Hyperamylasemia
  • Hypertriglyceridemia
  • Hypercholesterolemia
  • Increased BUN
  • HCO3 < 15 (< 15 mmol/L)
  • Decreased calculated total body K+
  • Metabolic acidosis on ABGs
  • Increased serum osmolality
  • Increased anion gap

Drugs that may alter lab results: N/A
Disorders that may alter lab results:

  • With concomitant lactic acidosis, acetoacetate production may be inhibited in presence of high levels of beta hydroxybutyrate. The nitroprusside reaction, which measures only acetoacetate, may not be strongly positive.
  • A very low serum sodium (< 110 mmol/L) suggests an artifact due to severe hypertriglyceridemia
  • Severe acidosis gives artificially high K+ level
  • Markedly increased serum ketones may cross react and cause a falsely high serum creatinine
PATHOLOGICAL FINDINGS

N/A

SPECIAL TESTS
  • ECG (especially if MI suspected). May also assist in evaluation of K+ status. Usually shows sinus tachycardia.
  • Urine and blood cultures
IMAGING

Chest x-ray to rule out pulmonary infection

DIAGNOSTIC PROCEDURES

N/A

TREATMENT

APPROPRIATE HEALTH CARE
  • Inpatient intensive care. This is a life threatening emergency.
  • Goals are to increase rate of glucose utilization by insulin-dependent tissues, to reverse ketonemia and acidosis, and to correct the depletion of water and electrolytes.
GENERAL MEASURES
  • IV Fluids adults: 1000 mL over first hour, then 500 mL/hr (approximately 7 mL/kg/hr) x 4 hrs or until dehydration improves, then 250 mL/hour (3.5 mL/kg/hr). Switch to D5 in 1/2 NS when serum glucose < 300 mg/dL (16.65 mmol/l). Expect to give 4-8 L/ first 24 hrs. (Some do not recommend initial IV bolus).
  • Pediatric maintenance requirements: 100 mL/kg for first 10 kg, 50 mL/kg for second 10 kg and 20 mL/kg thereafter. Fluid deficit: (Multiply patient's body weight by percentage dehydration). Replace maintenance and deficit evenly over 48 hours.
SURGICAL MEASURES

N/A

ACTIVITY

Bedrest

DIET

Nothing by mouth initially. Advance to pre-ketotic diet when nausea and vomiting are controlled.

PATIENT EDUCATION
  • For prevention, careful control of blood glucose (usually HgbA1c 7%)
  • Monitor glucose carefully during periods of stress, infection, trauma etc.

FOLLOW UP

PREVENTION/AVOIDANCE
  • Monitor glucose closely during stressful situations
  • Careful insulin control
POSSIBLE COMPLICATIONS
  • Cerebral edema
  • Pulmonary edema
  • Venous thrombosis
  • Hypokalemia
  • Myocardial infarction
  • Acute gastric dilatation
  • Late hypoglycemia
  • Erosive gastritis
  • Infection
  • Respiratory distress
  • Hypophosphatemia
  • Mucormycosis
EXPECTED COURSE AND PROGNOSIS
  • DKA accounts for 14% of all hospital admissions for diabetes and for 16% of all diabetic related fatalities
  • Overall mortality of 5-15%
  • In children < 10 years old, DKA causes 70% diabetes related fatalities

MISCELLANEOUS

ASSOCIATED CONDITIONS

Look for complications of chronic diabetes (nephropathy, neuropathy, retinopathy, etc.)

AGE-RELATED FACTORS

Pediatric:

  • Occasionally children or adolescents with DKA exhibit marked mental deterioration, including development of coma 4-6 hrs after therapy has begun. Mortality is high.
    • Diagnose by CT scan (cerebral edema)
    • Treat with IV bolus of 1 gram mannitol/kg in 20% solution
    • If no response, hyperventilation to a pCO2 of 28 mm Hg

Geriatric: Must be careful with renal status or congestive heart failure
Others: N/A

PREGNANCY

Risk of fetal death with DKA during pregnancy is nearly 50%

OTHER NOTES

N/A

ABBREVIATIONS

NS = normal saline
ABG = arterial blood gases
D5 = 5% dextrose

Clinical Investigations

ROLE OF HOMOEOPATHY

Copyright © 2025 Selkey. All Rights Reserved.